(Q42670935)

English

Pharmacokinetic evaluation of doxorubicin plasma levels in normal and overweight patients with breast cancer and simulation of dose adjustment by different indexes of body mass

scientific article published on August 3, 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Pharmacokinetic evaluation of doxorubicin plasma levels in normal and overweight patients with breast cancer and simulation of dose adjustment by different indexes of body mass (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

0 references

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Pedro Eduardo Fröehlich

3

object named as

Pedro Eduardo Froehlich

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20688160

17 June 2024

author name string

Deise Raquel Barpe

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Daniela Dornelles Rosa

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

language of work or name

0 references

publication date

3 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0928098710002824?httpAccept=text/xml

1 reference

10.1016/J.EJPS.2010.07.015

https://api.crossref.org/works/10.1016/J.EJPS.2010.07.015

17 June 2024

https://api.elsevier.com/content/article/PII:S0928098710002824?httpAccept=text/plain

1 reference

10.1016/J.EJPS.2010.07.015

https://api.crossref.org/works/10.1016/J.EJPS.2010.07.015

17 June 2024

European Journal of Pharmaceutical Sciences

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

3-4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

458-463

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001.

1

1 reference

10.1016/J.EJPS.2010.07.015

https://api.crossref.org/works/10.1016/J.EJPS.2010.07.015

17 June 2024

Overweight as an avoidable cause of cancer in Europe.

2

1 reference

10.1016/J.EJPS.2010.07.015

https://api.crossref.org/works/10.1016/J.EJPS.2010.07.015

17 June 2024

Anthracycline antibiotics in cancer therapy. Focus on drug resistance

3

1 reference

10.1016/J.EJPS.2010.07.015

https://api.crossref.org/works/10.1016/J.EJPS.2010.07.015

17 June 2024

Determination of doxorubicin and doxorubicinol in plasma of cancer patients by high-performance liquid chromatography

4

1 reference

10.1016/J.EJPS.2010.07.015

https://api.crossref.org/works/10.1016/J.EJPS.2010.07.015

17 June 2024

Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B

5

1 reference

10.1016/J.EJPS.2010.07.015

https://api.crossref.org/works/10.1016/J.EJPS.2010.07.015

17 June 2024

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

6

1 reference

10.1016/J.EJPS.2010.07.015

https://api.crossref.org/works/10.1016/J.EJPS.2010.07.015

17 June 2024

Rapid determination of PEGylated liposomal doxorubicin and its major metabolite in human plasma by ultraviolet-visible high-performance liquid chromatography.

7

1 reference

10.1016/J.EJPS.2010.07.015

https://api.crossref.org/works/10.1016/J.EJPS.2010.07.015

17 June 2024

Obesity, Tamoxifen Use, and Outcomes in Women With Estrogen Receptor-Positive Early-Stage Breast Cancer

8

1 reference

10.1016/J.EJPS.2010.07.015

https://api.crossref.org/works/10.1016/J.EJPS.2010.07.015

17 June 2024

Chemotherapy dosing strategies in the obese, elderly, and thin patient: results of a nationwide survey

9

1 reference

10.1016/J.EJPS.2010.07.015

https://api.crossref.org/works/10.1016/J.EJPS.2010.07.015

17 June 2024

Factors affecting epirubicin pharmacokinetics and toxicity: evidence against using body-surface area for dose calculation

12

1 reference

10.1016/J.EJPS.2010.07.015

https://api.crossref.org/works/10.1016/J.EJPS.2010.07.015

17 June 2024

Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative

13

1 reference

10.1016/J.EJPS.2010.07.015

https://api.crossref.org/works/10.1016/J.EJPS.2010.07.015

17 June 2024

Body surface area as a determinant of pharmacokinetics and drug dosing

17

1 reference

10.1016/J.EJPS.2010.07.015

https://api.crossref.org/works/10.1016/J.EJPS.2010.07.015

17 June 2024

The persistence of adriamycin in man and rat.

18

1 reference

10.1016/J.EJPS.2010.07.015

https://api.crossref.org/works/10.1016/J.EJPS.2010.07.015

17 June 2024

Identifiers

10.1016/J.EJPS.2010.07.015

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42670935&oldid=2182009331"